Taking metformin during SARS-CoV-2 infection cuts risk of lo

People who took the diabetes drug metformin after being infected with SARS-CoV-2 were less likely to develop long COVID in a randomized clinical trial.

Related Keywords

, Harvard Medical School Jeremy Samuel Faust , New England Journal , Lancet Infectious , Harvard Medical School , Jeremy Samuel Faust , Metformin , Ars Cov 2 , Covid , Long Covid , Diabetes Drug , Randomized Clinical Trial ,